doxorubicin,nivolumab
teva,bms,sopherion
['nivahl study', 'nivahl trial', 'nivo', 'lymsm', 'nivolumab']
nivahl study schema &amp; detailed, in-depth evaluation of all aes - the main room for improvement is hypothyroidism, although follow up is early for assessment of second primary malignancies #ash22 #lymsm 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer